F
T. Opsomer et al.
Special Topic
Synthesis
raphy after cooling down to r.t. CH2Cl2 was used at first as the eluent
to remove PNA, followed by a heptane–EtOAc or CH2Cl2–EtOAc gradi-
ent to afford the corresponding 1,2,3-triazoles.
1H NMR (CDCl3, 300 MHz): δ = 8.52 (s, 1 H, indole NH), 7.64–7.58 (m,
2 H), 7.39–7.29 (m, 4 H), 7.28–7.13 (m, 5 H), 7.09–7.03 (m, 1 H), 6.90–
6.84 (m, 2 H), 6.78 (d, J = 2.3 Hz, 1 H), 4.34 (t, J = 7.3 Hz, 2 H), 3.80 (s, 2
H), 3.24 (t, J = 7.2 Hz, 2 H).
13C NMR (CDCl3, 75 MHz): δ = 145.53, 136.26, 136.19, 131.48, 131.34,
128.97, 128.75, 127.89, 127.73, 127.27, 127.05, 126.91, 122.71,
122.13, 119.51, 118.14, 111.43, 111.11, 48.89, 28.12, 26.39.
Note: The reactions to obtain compounds 7aa–ae were performed
without AcOH.
5-Benzyl-1-(4-methoxybenzyl)-4-phenyl-1H-1,2,3-triazole (5aa)
HRMS (ESI-Q-TOF): m/z [M + H]+ calcd for C25H22N4: 379.1917; found:
379.1923.
Prepared according to the triazolization procedure, using 1,3-
DPA (1a; 105.1 mg, 0.5 mmol), PMBA (2a; 68.6 mg, 0.5 mmol), 4-
NPA (3; 164.1 mg, 1 mmol), and AcOH (30 mg, 0.5 mmol); yellow sol-
id; yield: 133.5 mg (75%); mp 104 °C.
1H NMR (CDCl3, 400 MHz): δ = 7.68–7.65 (m, 2 H), 7.41–7.23 (m, 6 H),
7.02 (d, J = 8.7 Hz, 2 H), 6.98 (d, J = 6.5 Hz, 2 H), 6.80 (d, J = 8.7 Hz, 2 H),
5.26 (s, 2 H), 4.09 (s, 2 H), 3.76 (s, 3 H).
13C NMR (CDCl3, 101 MHz): δ = 159.54, 146.42, 136.01, 131.28,
130.84, 129.02, 128.74, 127.92, 127.78, 127.18, 127.08, 126.64,
114.23, 55.28, 51.75, 28.58.
5-Benzyl-1-{[(1R,4aS,10aR)-7-isopropyl-1,4a-dimethyl-
1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl]methyl}-4-phe-
nyl-1H-1,2,3-triazole (5ae)
Prepared according to the triazolization procedure, using 1,3-
DPA (1a; 105.1 mg, 0.5 mmol), (+)-dehydroabietylamine (2e; 143 mg,
0.5 mmol), 4-NPA (3; 164.1 mg, 1 mmol,), and AcOH (30 mg,
0.5 mmol); yellow semi-solid; yield: 143.5 mg (57%).
1H NMR (CDCl3, 300 MHz): δ = 7.67–7.62 (m, 2 H), 7.41–7.23 (m, 6 H),
7.13 (d, J = 8.2 Hz, 1 H), 7.02–6.94 (m, 3 H), 6.91–6.88 (m, 1 H), 4.36
(d, J = 17.3 Hz, 1 H), 4.22 (d, J = 17.4 Hz, 1 H), 4.16 (d, J = 14.3 Hz, 1 H),
3.80 (d, J = 14.3 Hz, 1 H), 3.14–2.74 (m, 3 H), 2.29–2.20 (m, 1 H), 2.08–
1.96 (m, 1 H), 1.90–1.55 (m, 4 H), 1.50–1.42 (m, 1 H), 1.35–1.18 (m, 11
H), 1.06 (s, 3 H).
13C NMR (CDCl3, 75 MHz): δ = 146.84, 145.69, 145.00, 136.27, 134.87,
132.12, 131.46, 129.09, 128.71, 127.80, 127.27, 127.16, 126.99,
124.10, 123.80, 58.19, 45.43, 39.29, 38.03, 37.63, 36.78, 33.46, 29.91,
29.07, 25.68, 24.05, 23.97, 19.40, 18.92, 18.54.
HRMS (ESI-Q-TOF): m/z [M + H]+ calcd for C23H21N3O: 356.1757;
found: 356.1761.
5-Benzyl-1-hexyl-4-phenyl-1H-1,2,3-triazole (5ab)
Prepared according to the triazolization procedure, using 1,3-
DPA (1a; 105.1 mg, 0.5 mmol), hexylamine (2b; 50.6 mg, 0.5 mmol),
4-NPA (3; 164.1 mg, 1 mmol), and AcOH (30 mg, 0.5 mmol); yellow
viscous oil; yield: 128.4 mg (80%).
1H NMR (CDCl3, 400 MHz): δ = 7.70–7.66 (m, 2 H), 7.41–7.36 (m, 2 H),
7.34–7.22 (m, 4 H), 7.06 (d, J = 7.1 Hz, 2 H), 4.24 (s, 2 H), 4.10 (t, J = 7.4
Hz, 2 H), 1.72 (pent, J = 7.4 Hz, 2 H), 1.28–1.15 (m, 6 H), 0.84 (t, J = 6.9
Hz, 3 H).
HRMS (ESI-Q-TOF): m/z [M + H]+ calcd for C35H41N3: 504.3373; found:
504.3371.
13C NMR (CDCl3, 101 MHz): δ = 145.63, 136.40, 131.49, 130.66,
129.04, 128.74, 127.83, 127.78, 127.20, 127.15, 48.32, 31.12, 29.77,
28.74, 26.19, 22.35, 13.93.
HRMS (ESI-Q-TOF): m/z [M + H]+ calcd for C21H25N3: 320.2121; found:
320.2118.
1-(4-Methoxybenzyl)-5-methyl-4-phenyl-1H-1,2,3-triazole (5ba)
Prepared according to the triazolization procedure, using
phenylacetone (1b; 67.1 mg, 0.5 mmol), PMBA (2a; 68.6 mg,
0.5 mmol), 4-NPA (3; 164.1 mg, 1 mmol), and AcOH (30 mg,
0.5 mmol); yellow viscous oil; yield: 102.0 mg (73%).
1H NMR (CDCl3, 400 MHz): δ = 7.68 (d, J = 7.5 Hz, 2 H), 7.42 (t, J = 7.5
Hz, 2 H), 7.32 (t, J = 7.3 Hz, 1 H), 7.16 (d, J = 8.3 Hz, 2 H), 6.86 (d, J = 8.4
Hz, 2 H), 5.47 (s, 2 H), 3.78 (s, 3 H), 2.33 (s, 3 H).
13C NMR (CDCl3, 101 MHz): δ = 159.55, 144.98, 131.66, 129.02,
128.66, 128.64, 127.59, 127.11, 126.84, 114.35, 55.30, 51.59, 9.22.
(R)-5-Benzyl-4-phenyl-1-(1-phenylethyl)-1H-1,2,3-triazole (5ac)
Prepared according to the triazolization procedure, using 1,3-
DPA (1a; 105.1 mg, 0.5 mmol), (R)-(+)-α-methylbenzylamine (2c;
60.6 mg, 0.5 mmol), 4-NPA (3; 164.1 mg, 1 mmol), and AcOH (30 mg,
0.5 mmol); off-white solid; yield: 142.8 mg (84%); mp 123 °C.
1H NMR (CDCl3, 400 MHz): δ = 7.68–7.64 (m, 2 H), 7.40–7.34 (m, 2 H),
7.33–7.20 (m, 7 H), 7.12–7.08 (m, 2 H), 7.00–6.96 (m, 2 H), 5.26 (q, J =
7.0 Hz, 1 H), 4.23 (d, J = 17.3 Hz, 1 H), 3.91 (d, J = 17.3 Hz, 1 H), 1.94 (d,
J = 7.1 Hz, 3 H).
HRMS (ESI-Q-TOF): m/z [M + H]+ calcd for C17H17N3O: 280.1444;
found: 280.1449.
1-(4-Methoxybenzyl)-4,5-diphenyl-1H-1,2,3-triazole (5ca)
Prepared according to the triazolization procedure, using
deoxybenzoin (1c; 98.1 mg, 0.5 mmol), PMBA (2a; 68.6 mg,
0.5 mmol), 4-NPA (3; 164.1 mg, 1 mmol), and AcOH (30 mg,
0.5 mmol); off-white solid; yield: 89.0 mg (52%); mp 88 °C.
1H NMR (CDCl3, 400 MHz): δ = 7.57–7.52 (m, 2 H), 7.51–7.40 (m, 3 H),
7.28–7.19 (m, 3 H), 7.18–7.13 (m, 2 H), 6.96 (d, J = 8.6 Hz, 2 H), 6.76
(d, J = 8.6 Hz, 2 H), 5.34 (s, 2 H), 3.76 (s, 3 H).
13C NMR (CDCl3, 101 MHz): δ = 159.43, 144.51, 133.68, 130.97,
130.16, 129.64, 129.15, 129.04, 128.41, 128.00, 127.64, 127.41,
126.70, 114.01, 55.26, 51.59.
13C NMR (CDCl3, 101 MHz): δ = 146.16, 140.71, 136.27, 131.38,
130.75, 129.02, 128.84, 128.70, 127.99, 127.85, 127.68, 127.24,
127.06, 126.12, 58.76, 28.62, 22.45.
HRMS (ESI-Q-TOF): m/z [M + H]+ calcd for C23H21N3: 340.1808; found:
340.1815.
3-[2-(5-Benzyl-4-phenyl-1H-1,2,3-triazol-1-yl)ethyl]-1H-indole
(5ad)
Prepared according to the triazolization procedure, using 1,3-
DPA (1a; 105.1 mg, 0.5 mmol), tryptamine (2d; 80.1 mg, 0.5 mmol),
4-NPA (3; 164.1 mg, 1 mmol), and AcOH (30 mg, 0.5 mmol); off-
white solid; yield: 136.5 mg (72%); mp 151 °C.
HRMS (ESI-Q-TOF): m/z [M + H]+ calcd for C22H19N3O: 342.1601;
found: 342.1609.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2017, 49, A–H